Silicon Laboratories Crecimiento futuro
Future controles de criterios 5/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Silicon Laboratories de 104% y 31.2% por año respectivamente. Se prevé que el BPA crezca en un 103.5% al año. Se espera que la rentabilidad financiera sea de 9.7% en 3 años.
Información clave
104.0%
Tasa de crecimiento de los beneficios
103.5%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Semiconductor | 28.2% |
Tasa de crecimiento de los ingresos | 31.2% |
Rentabilidad financiera futura | 9.7% |
Cobertura de analistas | Good |
Última actualización | 22 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
A Slower, More Stretched-Out Recovery Has Weighed On Silicon Labs
Nov 05Pinning Down Silicon Laboratories Inc.'s (NASDAQ:SLAB) P/S Is Difficult Right Now
Nov 01Silicon Laboratories: A Questionable Outlook Offsets Improving Results
Oct 17Silicon Laboratories: Equity Story Remains Very Attractive
Jul 31Silicon Labs Ready For The Next IoT-Fueled Run
Jul 14Investor Optimism Abounds Silicon Laboratories Inc. (NASDAQ:SLAB) But Growth Is Lacking
Jul 11Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Could Be 31% Below Their Intrinsic Value Estimate
Jun 20Silicon Laboratories: An Uncertain Recovery Outlook Continues To Linger
May 05We Think Some Shareholders May Hesitate To Increase Silicon Laboratories Inc.'s (NASDAQ:SLAB) CEO Compensation
Apr 13Silicon Laboratories Inc.'s (NASDAQ:SLAB) Business Is Trailing The Industry But Its Shares Aren't
Mar 26Health Check: How Prudently Does Silicon Laboratories (NASDAQ:SLAB) Use Debt?
Feb 19Silicon Laboratories: Upgrade To Neutral As Near-Term Bear Case Is In Focus
Feb 11Are Investors Undervaluing Silicon Laboratories Inc. (NASDAQ:SLAB) By 31%?
Feb 01Silicon Laboratories: Why The Stock Could Be Heading Lower
Jan 30At US$132, Is It Time To Put Silicon Laboratories Inc. (NASDAQ:SLAB) On Your Watch List?
Jan 02Silicon Laboratories Inc. (NASDAQ:SLAB) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Dec 18Is Silicon Laboratories (NASDAQ:SLAB) A Risky Investment?
Nov 02Is It Time To Consider Buying Silicon Laboratories Inc. (NASDAQ:SLAB)?
Sep 29A Look At The Fair Value Of Silicon Laboratories Inc. (NASDAQ:SLAB)
Sep 11Silicon Laboratories Inc. (NASDAQ:SLAB) Analysts Just Slashed This Year's Revenue Estimates By 11%
Aug 04Is Now The Time To Put Silicon Laboratories (NASDAQ:SLAB) On Your Watchlist?
Jul 28Here's Why Silicon Laboratories (NASDAQ:SLAB) Can Manage Its Debt Responsibly
Jul 10Is It Time To Consider Buying Silicon Laboratories Inc. (NASDAQ:SLAB)?
May 29Is Silicon Laboratories (NASDAQ:SLAB) Using Too Much Debt?
Apr 10Is It Time To Consider Buying Silicon Laboratories Inc. (NASDAQ:SLAB)?
Feb 13Silicon Laboratories (NASDAQ:SLAB) Seems To Use Debt Quite Sensibly
Dec 19What Is Silicon Laboratories Inc.'s (NASDAQ:SLAB) Share Price Doing?
Oct 17Silicon Laboratories Is Nearing An Important Junction (Technical Analysis)
Sep 26An Intrinsic Calculation For Silicon Laboratories Inc. (NASDAQ:SLAB) Suggests It's 27% Undervalued
Sep 26Silicon Labs' board authorizes additional $200M share repurchase
Aug 29Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 1,013 | 27 | 127 | 145 | 2 |
12/31/2025 | 806 | -47 | -1 | 11 | 8 |
12/31/2024 | 584 | -174 | -59 | -48 | 8 |
9/28/2024 | 505 | -237 | -17 | -6 | N/A |
6/29/2024 | 542 | -198 | -85 | -71 | N/A |
3/30/2024 | 642 | -105 | -106 | -89 | N/A |
12/30/2023 | 782 | -35 | -53 | -30 | N/A |
9/30/2023 | 953 | 61 | -60 | -35 | N/A |
7/1/2023 | 1,019 | 71 | -16 | 12 | N/A |
4/1/2023 | 1,037 | 82 | -46 | -17 | N/A |
12/31/2022 | 1,024 | 91 | 45 | 72 | N/A |
10/1/2022 | 975 | 72 | -190 | -160 | N/A |
7/2/2022 | 890 | 31 | -164 | -134 | N/A |
4/2/2022 | 797 | -10 | -67 | -40 | N/A |
1/1/2022 | 721 | -58 | -129 | -100 | N/A |
10/2/2021 | 658 | -85 | 103 | 127 | N/A |
7/3/2021 | 606 | -92 | 94 | 114 | N/A |
4/3/2021 | 551 | -109 | 71 | 91 | N/A |
1/2/2021 | 511 | -115 | 118 | 136 | N/A |
10/3/2020 | 585 | -84 | 142 | 159 | N/A |
7/4/2020 | 675 | -38 | 180 | 196 | N/A |
4/4/2020 | 767 | -18 | 178 | 194 | N/A |
12/28/2019 | 474 | -103 | 151 | 167 | N/A |
9/28/2019 | 834 | 25 | 144 | 163 | N/A |
6/29/2019 | 841 | 32 | 172 | 194 | N/A |
3/30/2019 | 851 | 63 | 159 | 183 | N/A |
12/29/2018 | 868 | 84 | 149 | 174 | N/A |
9/29/2018 | 854 | 64 | 173 | 193 | N/A |
6/30/2018 | 822 | 56 | N/A | 160 | N/A |
3/31/2018 | 795 | 58 | N/A | 170 | N/A |
12/30/2017 | 769 | 47 | N/A | 190 | N/A |
9/30/2017 | 750 | 72 | N/A | 164 | N/A |
7/1/2017 | 730 | 72 | N/A | 149 | N/A |
4/1/2017 | 715 | 71 | N/A | 129 | N/A |
12/31/2016 | 698 | 61 | N/A | 129 | N/A |
10/1/2016 | 675 | 47 | N/A | 125 | N/A |
7/2/2016 | 653 | 37 | N/A | 129 | N/A |
4/2/2016 | 643 | 29 | N/A | 124 | N/A |
1/2/2016 | 645 | 30 | N/A | 105 | N/A |
10/3/2015 | 647 | 34 | N/A | 117 | N/A |
7/4/2015 | 649 | 30 | N/A | 111 | N/A |
4/4/2015 | 639 | 36 | N/A | 115 | N/A |
1/3/2015 | 621 | 38 | N/A | 137 | N/A |
9/27/2014 | 605 | 39 | N/A | 133 | N/A |
6/28/2014 | 594 | 40 | N/A | 117 | N/A |
3/29/2014 | 580 | 38 | N/A | 138 | N/A |
12/28/2013 | 580 | 50 | N/A | 120 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que SLAB sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.6%).
Beneficios vs. Mercado: Se prevé que SLAB sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.
Beneficios de alto crecimiento: Se espera que SLAB sea rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (31.2% al año) de SLAB crezcan más rápidamente que los del mercado US (8.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos (31.2% al año) de SLAB crezcan más rápidamente que un 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de SLAB sea baja dentro de 3 años (9.7%).